Opportunities open up for SA drug companies
Sub-Saharan Africa offers significant opportunities for SA's pharmaceutical manufacturing companies‚ as a growing middle class and an increasing disease burden push up demand for medicines‚ according to research by Frost & Sullivan.
Pharmaceutical sales in sub-Saharan Africa generated revenues of US$2.28bn in 2011 and were forecast to reach US$5.02bn in 2018‚ the research company said on Wednesday (16.... Read more »
Posted on : Wednesday , 13th August 2014